Biogen Inc (NASDAQ:BIIB)

282.27
Delayed Data
As of Nov 15
 +7.12 / +2.59%
Today’s Change
215.78
Today|||52-Week Range
344.00
-6.20%
Year-to-Date
Here's Why Biogen Stock Shot Up 28% in October
Nov 10 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks Fighting Alzheimers Disease to Own Now
Nov 09 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen vs. Celgene
Nov 10 / MotleyFool.com - Paid Partner Content
Biogen's Alzheimer's Drug Goes From Bust to Boon, Plus Why Walgreens Is Shuttering 200 Healthcare Clinics
Nov 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close275.15
Today’s open278.25
Day’s range277.11 - 283.95
Volume1,922,192
Average volume (3 months)1,841,279
Market cap$50.9B
Data as of 4:00pm ET, 11/15/2019

Growth & Valuation

Earnings growth (last year)+81.10%
Earnings growth (this year)+26.43%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+9.67%
P/E ratio10.0
Price/Sales5.13
Price/Book4.27

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+7.55+2.53%
GILDGilead Sciences+1.26+1.97%
BMRNBiomarin Pharmaceuti...-0.54-0.71%
EXASExact Sciences Corp+2.81+3.55%
Data as of 4:15pm ET, 11/15/2019

Financials

Next reporting dateJanuary 29, 2020
EPS forecast (this quarter)$7.92
Annual revenue (last year)$12.1B
Annual profit (last year)$4.4B
Net profit margin36.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts